Biomarkers US 2023

Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine

Ania-Ariadna Baetica

Dr. Ania-Ariadna Baetica is an Assistant Professor in the Department of Mechanical Engineering and Mechanics at Drexel University. She received her BA degree from Princeton University in 2012 and her PhD from California Institute of Technology in 2018. Following her degrees, she was a postdoctoral scholar at the University of California San Francisco.

Dr. Baetica’s group leverages control theory along with systems biology, synthetic biology, and computational science to solve biotechnological and medical challenges. Her group designs robust and modular synthetic biological circuits by incorporating layered feedback mechanisms.

Samuel Gowland

I grew up just outside of Atlanta, GA and have spent the past ten years pursuing my research interests in synthetic biology, culminating in earning my PhD at Northwestern University. I am now focused on bringing on continuing to pursue impactful research while also bringing what I’ve learned back home. Ultimately, I hope to contribute to building up Atlanta as a regional bioeconomy hub with world-class opportunities for synthetic biology education and biomanufacturing.

Ian Ehrenreich

My lab studies how genomes encode organisms’ phenotypes. To do this, we use techniques from genetics, molecular systems biology, and synthetic biology. In the area of synthetic biology, we have developed new approaches for building synthetic chromosomes from natural DNA.

RNA Therapeutics & Delivery Europe 2023

Join RNA leaders, experts and distinguished scientists in Europe, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations within the formulation and delivery of RNA-based therapeutics.

Project Manager – Task Force on Global Metrics and Technical Standards for the Bioeconomy

Job Summary

This post offers a truly exciting opportunity to be the Project Manager of a global task force focused on determining the engineering biology metrics and technical standards needed to accelerate the global bioeconomy.

The project has key partners in the US (EBRC, NIST) as well as in Singapore at NUS and will involve extensive external stakeholder engagement with the international synthetic biology/engineering biology industry including start-ups and SMEs, policymakers, regulators, national measurement labs and bioindustry trade bodies and associations. These external engagements will feed into the organisation and coordination of three physical workshops in the US, EU and Asia with a fourth workshop bringing together all stakeholders to map a way forward.

The post would suit an ambitious, enthusiastic person with strong program/project management skills, who is passionate about engineering biology and the future bioeconomy and the transition to a more sustainable future and is keen to play an international role.

Duties and responsibilities

You will oversee and coordinate the management of the project through regular meetings with partners and associated stakeholders and direct international stakeholder engagement. You will contribute to the organization of workshops and lead on the delivery of workshop reports. You will ensure good communication to the project funders and project partners and direct and lead the production, revision, and dissemination of a strategic roadmap including identifying technical contributors and reviewers and overseeing the work of the science writer.

Essential requirements

The task force project manager will have:

Degree or equivalent qualification/experience and knowledge of synthetic biology/engineering biology

Demonstrated success in a similar project

Excellent written and verbal communication skills

Experience in appropriate events management, including organising large and small project meetings and events, drafting agendas and taking minutes

Communications experience including producing marketing, social media and website material

Experience of coordinating complex funding bids and/or reports that involve multiple stakeholders

Proven ability to prioritise, plan ahead and manage a high volume of work to meet deadlines, to and ensure that the operation runs in an efficient and timely manner

Ability to work collaboratively and productively with colleagues and multiple stakeholders in different geographical locations

Further Information

This is a full time, fixed term position for up to 15 months. You will be based at South Kensington Campus.

Should you require any further details on the role please contact: India Hook-Barnard (EBRC; ihb@ebrc.org) or Paul Freemont (Imperial College; p.freemont@imperial.ac.uk )

Seokmu Kwon

Kwon is from South Korea and graduated with a BS in Chemical Engineering from POSTECH (Pohang University of Science and Technology) in South Korea. He trained in cellular engineering while doing research related to metabolic engineering during his undergraduate. He is also the recipient of the Korean government scholarship for study overseas (KGSPSO). Kwon is broadly interested in synthetic biology, protein engineering, and their application in biomedical fields such as developing novel living therapeutics.

Oligonucleotides Chemistry & Therapeutics Europe 2023

Join oligo leaders, experts and distinguished scientists in Europe, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations within the oligonucleotides chemistry & therapeutics development.

Chelsea Hu

I’m a new faculty at Texas A&M studying synthetic biology and control theory. Before moving to Texas, I completed four years of postdoctoral training in the Richard Murray Group at Caltech. I received my Ph.D. in Chemical and Biomolecular Engineering from Cornell University in 2018, advised by Julius B. Lucks.

Field Applications Scientist – Europe

Inscripta is expanding its Global Support team into Europe! We’re seeking an experienced, dynamic, customer-centric Field Applications Scientist (FAS) to support the world’s first scalable platform for benchtop Digital Genome Engineering. This role can be based in any major city in Germany, UK, Denmark, Sweden or the Netherlands. The FAS will combine technical expertise in genome editing and/or synthetic biology with commercial experience supporting customers conducting NGS, data analysis, and bioinformatics workflows. Come join our talented team and be a part of the exciting revolution in genome writing technology!

Jacob Barnett

I am an evolutionary biologist and science educator currently pursuing a PhD at UMass Amherst, where I am studying the evolutionary genetics of tomato flavor. A former middle and high school science teacher with an M.Ed., I find great joy in cultivating curiosity and connecting people to the natural world. I am particularly excited about engineering biology’s potential to solve urgent problems such as climate change, food security, sustainability, and health.

Matt Demelo

I am interested in developing novel molecular tools for manipulating genomes for medicine and synthetic biology, namely using CRISPR-based gene editing tools. Currently, I am working on using a prime editing-based DNA recorder to understand the causes of cisplatin resistance in cancer cells. I obtained my BS in Microbiology from UC San Diego, where I worked in Professor Rachel J. Dutton’s lab studying molecular interactions between various species in microbial consortia (in cheese!). After graduating, I worked in the biotechnology and biopharmaceutical industries, spending time at Illumina, Ambrx, and Omniome (now acquired by PacBio). Outside of the lab, I enjoy hiking, camping, cooking, and having long conversations with my opinionated husky, Kayuh.

Jetendra Roy

Elise Zimmerman

In 2022, I graduated Magna Cum Laude from William & Mary with a B.S. in Biology and a minor in Chemistry. I conducted undergraduate honors research which cumulated in a thesis on the plasticity of the H. pylori methylome in response to acid. Currently, I’m a first-year Ph.D. student in the Systems, Synthetic, and Physical Biology Program at Rice University working in the Chappell Lab on creating a new class of programmable, synthetic RNA-based therapeutics to address global health infectious disease challenges.

Ha Eun Lim

I’m a first year PhD student in Rice University co-advised by Dr. James Chappell and Dr. Laura Segatori. I am working on a project installing RNA sensors in mammalian cells in order to sense inflammation signals and respond with proteins of interest. I graduated from Cornell University with honors in Biomedical Engineering and minor in Computer science in May 2022.

Gene Therapy Development & Manufacturing 2023

Gene Therapy Development & Manufacturing 2023 delivers in-depth discussion on optimised process strategies and technologies for the successful technical development and manufacture of advanced gene therapy products.

Dalton George

My background is in the field of science, technology, and society studies, with a specific focus on the social and ethical dimensions of emerging biotechnologies. I did my PhD at North Carolina State University, where I focused on responsible research and innovation related to environmental and agricultural biotechnologies. My work as a post-doc at Arizona State focuses on the social, ethical, and political dimensions of synthetic biology, with a focus on issues related to biocontainment.

Yangruirui Zhou

Yangruirui Zhou is a third-year Doctor of Philosophy (Ph.D.) student in Computer Engineering Department, Boston University (BU). In Boston University, he is working with Professor Douglas Densmore. Yangruirui got his Bachelor of Engineering (B.E.) in software engineering (Elite Program) from the University of Electronic Science and Technology of China (UESTC)” in 2020. And he was honored with the “Most Outstanding students of UESTC 2019 (成电杰出学生)”, which is the highest honor for undergraduate student in UESTC.

Samuel MD Oliveira

I am a Research Assistant Professor at the Department of Electrical and Computer Engineering (ECE) and the director of the Oliveira Lab (www.oliveiralab.me), a recently created research group at Boston University (BU). In addition, I am the Senior Manager of the DAMP lab (www.damplab.org) at BU.

The Oliveira lab investigates the emergence of microbial community complexity and their underlying interactions in varying environmental contexts and studies microbial community design principles and metrics to help build novel collective behaviors. We hope that breakthroughs in computational and synthetic biology methods will accelerate our knowledge of the links between genetic sequences and intercellular communication to study and engineer the spatiotemporal behavior of biological networks. Among my key collaborators: i) Prof. Chris Voigt (MIT) for improving the predictive DNA design automation tool named Cello (Genetic Circuit Design Automation with Cello 2.0. Nature Protocols).

In my early career, I have published more than 30 articles in journals, conference proceedings, and book chapters, acted as the guest Editor for JoVE, and as a reviewer for Nat. Comm., ACS Synth. Biol., Synth. Biol. J., among others. In addition, I have directly supervised and co-supervised 7 research staff, 7 graduate students (none of whom received their Ph.D. with me), 3 master’s students, and over 14 undergraduates. I was one of the recipients of the Sao Paulo Foundation’s Best Innovative Biotech Product Award in 2019. Based on that, I co-founded a commercial synthetic biology, automation-based company named Doroth (www.doroth.com.br) in Brazil.

Currently, with the support from a $1.4M NSF grant, BU’s Professor Douglas Densmore (co-PI), Prof. Andrews (PI) from UMass Amherst, and my team (technical lead support) are teaming up on an ambitious effort to create microscopic, programmable “living devices” which can detect and neutralize specific toxic contaminants found in drinking water.

Maram Naji

I am a chemical and biological engineering PhD student in the Lucks Lab at Northwestern’s Center for Synthetic Biology. My research centers on targeting riboswitches with antibiotics. I began working toward new infectious disease treatments as an undergraduate researcher in the Nuermberger Lab at the Johns Hopkins Center for Tuberculosis Research. I have also held internships in drug discovery, high throughput biology, and biomarker development at pharmaceutical companies and aim to use synthetic biology to expedite drug discovery and development in my career.

Back to top ⇑